Androgen receptor agonist and antagonist reduce response of cytokine‐induced killer cells on prostate cancer cells

Despite many advances, prostate cancer (PCa) is still the second most frequently diagnosed cancer and fifth leading cause of cancer death in men worldwide. So far, the promising field of onco‐immunology has not yet provided a satisfactory treatment option for PCa. Here we show that the ex vivo expan...

Descripción completa

Detalles Bibliográficos
Autores principales: Pungsrinont, Thanakorn, Schneider, Margret Ann, Baniahmad, Aria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538273/
https://www.ncbi.nlm.nih.gov/pubmed/37639523
http://dx.doi.org/10.1111/jcmm.17923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538273/
https://www.ncbi.nlm.nih.gov/pubmed/37639523
http://dx.doi.org/10.1111/jcmm.17923

Ejemplares similares